IPSC vs PCG · rev $6.6M vs P/E 13, $37.68B cap
Century Therapeutics Inc (IPSC) versus PG&E Corp (PCG) — a side-by-side from cached financials, not a winner call.
Century Therapeutics Inc (IPSC) is a biotechnology company listed on US.
PG&E Corp (PCG) is a utilities - regulated electric company listed on US.
Latest reported IPSC revenue for 2024-12-31 was $6.6M. Net income was -$126.6M. Revenue was up 194.8% from 2023-12-31 to 2024-12-31. IPSC currently screens at market cap $47.8M.
PCG does not have a complete income-statement cache yet.
IPSC currently screens at market cap $47.8M. PCG currently screens at market cap $37.68B and trailing P/E 13.3.
Not investment advice. Open the IPSC and PCG stock pages for the full models.
Not investment advice.